Lexicon Pharmaceuticals, Inc. (LXRX)

NASDAQ: LXRX · Real-Time Price · USD

0.715

-0.009 (-1.23%)

At close: Dec 20, 2024, 4:00 PM

0.642

-0.073 (-10.17%)

After-hours: Dec 20, 2024, 7:55 PM EST

Lexicon Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for LXRX stock has a target of 6.00, which predicts an increase of 739.51% from the current stock price of 0.71.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$6.00	$6.00	$6.00	$6.00
Change	+739.51%	+739.51%	+739.51%	+739.51%

* Price targets were last updated on Nov 13, 2024.

Analyst Ratings

The average analyst rating for LXRX stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Stringer Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Nov 25, 2024
Joseph Stringer Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Nov 22, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+739.51%	Nov 13, 2024
Joseph Stringer Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Nov 13, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+739.51%	Nov 5, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

11.88M

from 1.20M

886.38%

from 1.20M

Revenue Next Year

33.44M

from 11.88M

181.58%

from 11.88M

EPS This Year

-0.69

from -0.80

EPS Next Year

-0.45

from -0.69

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	322.07M	24.00M	298.00K	139.00K	1.20M	11.88M	33.44M	84.19M
Revenue Growth	409.54%	-92.55%	-98.76%	-53.36%	766.19%	886.38%	181.58%	151.76%
EPS	1.16	-0.53	-0.60	-0.62	-0.80	-0.69	-0.45	-0.35
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	32.9M	63.5M	155.5M
Avg	11.9M	33.4M	84.2M
Low	6.4M	5.6M	22.7M

Revenue Growth

Revenue Growth	2024	2025	2026
High	2,629.7%	434.9%	365.0%
Avg	886.4%	181.6%	151.8%
Low	429.1%	-53.0%	-32.0%

EPS Forecast

EPS	2024	2025	2026
High	-0.64	-0.33	-0.22
Avg	-0.69	-0.45	-0.35
Low	-0.74	-0.64	-0.64

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.